BC101
bicara
['cara thera', 'bicara']
new data from the ongoing phase 1/1b trial of our lead program, bca101, have been presented at the #esmo2022 annual congress. more details here: 
Clinical stage biotech developing biologics that combine targeted therapy & immunotherapy to provide meaningful & safer therapies to cancer patients